BPC-157/TB-500 Blend
RecoveryPreclinicalAlso known as: BPC/TB Blend, BPC TB Stack
Combined healing peptide blend.
Overview
At A Glance
A combination of BPC-157 and TB-500 in a single formulation. Provides synergistic tissue repair through BPC-157's angiogenic properties and TB-500's actin upregulation for cellular repair.
Chemical Information
IUPAC Name
Not yet available
CAS Number
Not yet available
Molecular Formula
Blend
Molecular Mass
Not yet available
Dosing & Protocols
Unlock Dosing Protocols
Free account gets you:
- View beginner, intermediate & advanced protocols
- See weight-based dosing calculations
- Access cycle length & frequency data
2,800+ researchers already in
Research
Unlock Research Data
Free account gets you:
- Browse PubMed study summaries
- See clinical trial phases & results
- Access mechanism of action details
2,800+ researchers already in
Interactions
Interaction Matrix
Contraindications
Active cancer. Pregnancy or breastfeeding. Known hypersensitivity to either compound.
Research Disclaimer
This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.
$49.99
up to $94.99
$4.7495
5
6
vial
Tracking since Mar 13, 2026 · 4 data points
Price History
3 data pointsVendors Selling BPC-157/TB-500 Blend
VANDL Labs
BioMyst Labs
Nova Peptides
ResearchChemHQ
Optimum Formula
How we score these vendors
Every supplier above is graded 0–100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank.
Related Compounds
View AllARA-290
RecoveryPreclinicalARA-290, also known as Cibinetide or pHBSP (Helix B Surface Peptide), is an 11-amino-acid peptide — QEQLERALNSS — designed to mimic a specific region of the tissue-protective surface of erythropoietin (EPO) without activating the classical hematopoietic EPO receptor that drives red blood cell production.
Bronchogen
RecoveryPreclinicalBronchogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
CAG
RecoveryPreclinicalCAG (often referring to a collagen-derived or cartilage-targeting peptide sequence) is a short research peptide studied for connective tissue and joint applications.
Cardiogen
RecoveryPreclinicalCardiogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cartalax
RecoveryPreclinicalCartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St.
Chonluten
RecoveryPreclinicalChonluten is a bioregulator preparation originating from Vladimir Khavinson's St.
View Full Dosage Guide →
Protocols, calculator & safety for BPC-157/TB-500 Blend
Research Score
0 PubMed studies
Quality Indicators
Data Completeness
75%COA Verification
10
Verified COAs
2
Vendors w/ COA
High verification rate (83%)
Latest test: 3/1/2026
Quick Facts
Half-Life
BPC-157: ~4 hours; TB-500: ~2–3 hours
Administration
Subcutaneous, Intramuscular
Trial Phase
Preclinical
Research Disclaimer
This information is for educational and research purposes only. Not intended as medical advice. Consult a healthcare professional before use.
Frequently Asked Questions
What is BPC-157/TB-500 Blend used for in research?
Combined healing peptide blend
What forms does BPC-157/TB-500 Blend come in?
BPC-157/TB-500 Blend is available in vial form.
How much does BPC-157/TB-500 Blend cost?
Prices start at $49.99 across 5 verified vendors.
How do I compare BPC-157/TB-500 Blend vendors?
Compare prices, payment methods, shipping, and COA scores across 5 vendors.
Research Tools
Related Compounds
View AllARA-290
RecoveryPreclinicalARA-290, also known as Cibinetide or pHBSP (Helix B Surface Peptide), is an 11-amino-acid peptide — QEQLERALNSS — designed to mimic a specific region of the tissue-protective surface of erythropoietin (EPO) without activating the classical hematopoietic EPO receptor that drives red blood cell production.
Bronchogen
RecoveryPreclinicalBronchogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
CAG
RecoveryPreclinicalCAG (often referring to a collagen-derived or cartilage-targeting peptide sequence) is a short research peptide studied for connective tissue and joint applications.
Cardiogen
RecoveryPreclinicalCardiogen is a short synthetic peptide developed in Russia by Vladimir Khavinson and his collaborators at the St.
Cartalax
RecoveryPreclinicalCartalax is a short synthetic peptide developed in Russia by Vladimir Khavinson and colleagues at the St.
Chonluten
RecoveryPreclinicalChonluten is a bioregulator preparation originating from Vladimir Khavinson's St.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.